Sonnet BioTherapeutics Holdings, Inc(NASDAQ:SONN) 
Sonnet BioTherapeutics Holdings, Inc., an oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding (FHAB) technology, which utilizes human single chain antibodies fragment that binds to and hitch...
Website: http://www.sonnetbio.com
Founded: 1999
Full Time Employees: 30
CEO: Pankaj Mohan
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.70
H 1.70
L 1.25
C 1.25
V 207,433
10EMA 1.25
20EMA 1.25
60EMA 1.25
120EMA 1.25
250EMA 1.25